July 24, 2015
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549-3720
Attention: Jeffrey Gabor
Re: | BioCardia, Inc. |
| Filed on July 23, 2019 File No. 333-230779 |
Ladies and Gentlemen:
BioCardia, Inc. (the “Company”) hereby respectfully requests withdrawal of its acceleration request filed on July 23, 2019 relating to its Registration Statement on Form S-1 (File No. 333-230779) (the “Registration Statement”). The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
If you have any questions regarding the foregoing, please contact our counsel, Nathan Robinson of Wilson Sonsini Goodrich and Rosati, Professional Corporation, at (512) 418-6483.
| Sincerely,
|
| ||
| By: | /s/ David McClung |
| |
|
| Name: | David McClung |
|
| Title: | Chief Financial Officer | ||
